Latest News & Articles from JJP Biologics News JJP BIOLOGICS ANNOUNCES POSITIVE TOP-LINE PHASE I TRIAL RESULTS OF JJP-1212, ITS ANTI-CD89 ANTAGONIST January 7, 2026JJP Biologics, a clinical-stage biotechnology company that specializes in the development of innovative biologics, today announces positive top-line… Read more Latest Videos SubscribeWant to Stay Informed? Get Our Latest UpdatesSubscribe to receive our regular updates I agree that my submitted data is being collected and stored. Leave this field empty if you're human: